OPTIMOX2, a large randomized phase II study of maintenance therapy or chemotherapy-free intervals (CFI) after FOLFOX in patients with metastatic colorectal cancer (MRC). AGERCOR study

• MAINDRAULT-GOEBEL F

収録刊行物

• Proc Am Soc Clin Oncol

  Proc Am Soc Clin Oncol 24 147s-, 2006

詳細情報

• CRID: 1572261550250197504
• NII論文ID: 10018863409
• データソース種別:
  • CiNii Articles